A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/194
A61K 31/575 (2006.01) C07J 9/00 (2006.01)
Patent
CA 1080620
ABSTRACT OF THE DISCLOSURE The administration of hyodeoxycholic acid (HDCA) with chenodeoxycholic acid (CDCA) effects a lowering of serum glutamic-oxaloacetic transaminase, serum glutamic- pyruvate transaminase and alkaline phosphatase in the blood relative to the administration of CDCA alone.
266535
Drees David T.
Imondi Anthony R.
LandOfFree
Safer dosage forms of chenodeoxycholic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Safer dosage forms of chenodeoxycholic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Safer dosage forms of chenodeoxycholic acids will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-86783